RemeGen Co., Ltd. (HKG:9995)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
79.35
-1.35 (-1.67%)
Sep 1, 2026, 4:08 PM HKT

RemeGen Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, RemeGen stock has a consensus rating of "Buy" and an average price target of $116.84. The average 1-year stock price forecast is 47.25% higher than the current stock price, while the lowest is $89.41 (+12.68%) and the highest is $144.84 (+82.53%).

Price Target: $116.84 (+47.25%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$89.41$116.84$113.47$144.84
Change+12.68%+47.25%+43.00%+82.53%

Analyst Ratings

The average analyst rating for RemeGen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy8998911
Buy444322
Hold444443
Sell000000
Strong Sell100000
Total171717151516

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
SPDB
No rating
SPDB
Buy
Maintains
$99.30
BuyMaintains$99.30+25.14%Aug 28, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$105.00$127.70
BuyMaintains$105.00$127.70+60.93%Aug 26, 2026
Unknown Analyst
Bank of China
No rating
Bank of China
Buy
Maintains
$114.00
BuyMaintains$114.00+43.67%Aug 26, 2026
Unknown Analyst
Morgan Stanley
No rating
Morgan Stanley
Hold
Maintains
$98.00
HoldMaintains$98.00+23.50%Aug 25, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$141.10$132.50
BuyMaintains$141.10$132.50+66.98%Aug 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
7.66B
from 3.25B
Increased by 135.62%
Revenue Next Year
4.49B
from 7.66B
Decreased by -41.39%
EPS This Year
7.83
from 1.29
Increased by 506.75%
EPS Next Year
1.29
from 7.83
Decreased by -83.47%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.42B772.11M1.08B1.72B3.25B7.66B
Revenue Growth
--45.78%40.26%58.54%89.36%135.62%
Gross Profit
1.36B500.06M825.68M1.37B2.84B7.19B
Gross Margin
95.28%64.77%76.24%79.81%87.22%93.82%
Operating Income
121.61M-1.19B-1.55B-1.42B139.86M4.55B
Net Income
276.26M-998.83M-1.51B-1.47B709.65M4.34B
EPS
----1.297.83
EPS Growth
-----506.75%
Forward PE
-----8.69
Free Cash Flow
-453.29M-1.49B-2.00B-907.71M757.58M3.40B
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High8.2B
Avg7.7B
Low7.4B

Revenue Growth

Revenue Growth202620272028
High
153.3%
Avg
135.6%
Low
128.7%

EPS Forecast

EPS202620272028
High9.60
Avg7.83
Low6.58

EPS Growth

EPS Growth202620272028
High
644.2%
Avg
506.7%
Low
409.8%